Revolutionizing Colorectal Cancer Screening with Novigenix Innovations
By Pedro Romero, Chief Medical Officer, Novigenix. Two recent original research papers published in the March edition of the New England Journal of Medicine highlight the momentum in screening for colorectal carcinoma (CRC) and high-risk colorectal adenomas. These developments mark a significant milestone in the fight against CRC and signal additional momentum for Novigenix’